Wedbush Maintains Scholar Rock(SRRK.US) With Buy Rating, Raises Target Price to $25
Analysts Offer Insights on Healthcare Companies: Curis (CRIS), Scholar Rock Holding (SRRK) and Travere Therapeutics (TVTX)
Scholar Rock Holding Analyst Ratings
TD Cowen Sticks to Its Buy Rating for Scholar Rock Holding (SRRK)
Scholar Rock Holding Analyst Ratings
Scholar Rock Holding Analyst Ratings
Scholar Rock Holding Analyst Ratings
Analysts' Top Healthcare Picks: Scholar Rock Holding (SRRK), Gilead Sciences (GILD)
Scholar Rock Holding (SRRK) Receives a Buy From Truist Financial
Buy Rating Affirmed for Scholar Rock Holding on Strong Drug Pipeline and Market Readiness
Scholar Rock Holding Analyst Ratings
Scholar Rock Holding Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Scholar Rock Holding, Maintains $30 Price Target
Buy Rating Justified by Scholar Rock's Promising Pipeline and Strategic Clinical Advancements
Analysts Are Bullish on Top Healthcare Stocks: Scholar Rock Holding (SRRK), Zimmer Biomet Holdings (ZBH)
Scholar Rock Holding Analyst Ratings
Scholar Rock Holding Analyst Ratings
Raymond James Initiates Coverage On Scholar Rock Holding With Strong Buy Rating, Announces Price Target of $30
Piper Sandler Remains a Buy on Scholar Rock Holding (SRRK)
Scholar Rock Holding Analyst Ratings
No Data
No Data